Published in Health Business Week, October 21st, 2005
"Circulating HGF is significantly increased in a number of thrombus-associated disorders. Since platelets play a pivotal role in thrombogenesis, the ability of HGF to interact with human platelets was investigated," wrote D. Pietrapiana and colleagues, University A. Avogadro.
"This paper shows for the first time that human platelets express HGF receptor, the Tyr kinase encoded by c-MET gene. At physiological concentrations HGF was found to inhibit both glycoprotein alphaIIb beta3 activation and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
Source: Health Business Week (2005-10-21)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.